This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
April 02, 2024
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
April 01, 2024
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024
Carisma Therapeutics Announces Changes to its Board of Directors
March 28, 2024
Vicore Announces Presentations at the 2024 American Thoracic Society International Conference
March 27, 2024
Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa
March 27, 2024
Vicore publishes the Annual Report for 2023
March 26, 2024
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
March 19, 2024
HealthCap portfolio company Fusion Pharmaceuticals to be acquired by AstraZeneca for up to USD 2.4 billion
March 19, 2024
Fusion Pharmaceuticals To Be Acquired By AstraZeneca, Accelerating Development Of Next-Generation Radioconjugates To Treat Cancer
March 19, 2024
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis